Ana M García1, S Machicado2, G Gracia3, I M Zarante4. 1. Instituto de Genética Humana, Pontificia Universidad Javeriana, Carrera 7 no. 40-62 edificio 32, Bogotá, 110231, Colombia. agarciag@javeriana.edu.co. 2. Hospital Universitario San Ignacio, Pontificia Universidad Javeriana, Carrera 7 no. 40-62, Bogotá, 110231, Colombia. smachicado@javeriana.edu.co. 3. Secretaría de Salud de Bogotá, Carrera 32 no. 12-81, Bogotá, 111611, Colombia. gmgracia@saludcapital.gov.co. 4. Instituto de Genética Humana, Pontificia Universidad Javeriana, Carrera 7 no. 40-62 edificio 32, Bogotá, 110231, Colombia. izarante@javeriana.edu.co.
Abstract
PURPOSE: The mortality rate for congenital diaphragmatic hernia (CDH) remains high and prevention efforts are limited by the lack of known risk factors. The aim of this study was to determine prevalence, risk factors, and neonatal results associated with CDH on a surveillance system hospital-based in Bogotá, Colombia. METHODS: The data used in this study were obtained from The Bogota Birth Defects Surveillance and Follow-up Program (BBDSFP), between January 2001 and December 2013. With 386,419 births, there were 81 cases of CDH. A case-control methodology was conducted with 48 of the total cases of CDH and 192 controls for association analysis. RESULTS: The prevalence of CDH was 2.1 per 10,000 births. In the case-control analysis, risk factors found were maternal age ≥35 years (OR, 33.53; 95 % CI, 7.02-160.11), infants with CDH were more likely to be born before 37 weeks of gestation (OR, 5.57; 95 % CI, 2.05-15.14), to weigh less than 2500 g at birth (OR, 9.05; 95 % CI, 3.51-23.32), and be small for gestational age (OR, 5.72; 95 % CI, 2.18-14.99) with a high rate of death before hospital discharge in the CDH population (CDH: 38 % vs BBDSFP: <1 %; p < 0.001). CONCLUSIONS: The prevalence of CDH calculated was similar to the one reported in the literature. CDH is strongly associated with a high rate of death before hospital discharge and the risk factors found were maternal age ≥35 years, preterm birth, be small for gestational age, and have low weight at birth. These neonatal characteristics in developing countries would help to identify early CDH. Prevention efforts have been limited by the lack of known risk factors and established epidemiological profiles, especially in developing countries.
PURPOSE: The mortality rate for congenital diaphragmatic hernia (CDH) remains high and prevention efforts are limited by the lack of known risk factors. The aim of this study was to determine prevalence, risk factors, and neonatal results associated with CDH on a surveillance system hospital-based in Bogotá, Colombia. METHODS: The data used in this study were obtained from The Bogota Birth Defects Surveillance and Follow-up Program (BBDSFP), between January 2001 and December 2013. With 386,419 births, there were 81 cases of CDH. A case-control methodology was conducted with 48 of the total cases of CDH and 192 controls for association analysis. RESULTS: The prevalence of CDH was 2.1 per 10,000 births. In the case-control analysis, risk factors found were maternal age ≥35 years (OR, 33.53; 95 % CI, 7.02-160.11), infants with CDH were more likely to be born before 37 weeks of gestation (OR, 5.57; 95 % CI, 2.05-15.14), to weigh less than 2500 g at birth (OR, 9.05; 95 % CI, 3.51-23.32), and be small for gestational age (OR, 5.72; 95 % CI, 2.18-14.99) with a high rate of death before hospital discharge in the CDH population (CDH: 38 % vs BBDSFP: <1 %; p < 0.001). CONCLUSIONS: The prevalence of CDH calculated was similar to the one reported in the literature. CDH is strongly associated with a high rate of death before hospital discharge and the risk factors found were maternal age ≥35 years, preterm birth, be small for gestational age, and have low weight at birth. These neonatal characteristics in developing countries would help to identify early CDH. Prevention efforts have been limited by the lack of known risk factors and established epidemiological profiles, especially in developing countries.
Authors: Inga Sandaite; Filip Claus; Frederik De Keyzer; Elisa Donè; Tim Van Mieghem; Leonardo Gucciardo; Philip DeKoninck; Jacques Jani; Mieke Cannie; Jan A Deprest Journal: Fetal Diagn Ther Date: 2010-10-20 Impact factor: 2.587
Authors: D Gallot; C Boda; S Ughetto; I Perthus; E Robert-Gnansia; C Francannet; H Laurichesse-Delmas; J Jani; K Coste; J Deprest; A Labbe; V Sapin; D Lemery Journal: Ultrasound Obstet Gynecol Date: 2007-03 Impact factor: 7.299
Authors: Maria Loane; Helen Dolk; Alan Kelly; Conor Teljeur; Ruth Greenlees; James Densem Journal: Birth Defects Res A Clin Mol Teratol Date: 2011-03-04
Authors: Julia Finn; Jonathan Suhl; Vijaya Kancherla; Kristin M Conway; Jacob Oleson; Alpa Sidhu; Eirini Nestoridi; Sarah C Fisher; Sonja A Rasmussen; Wei Yang; Paul A Romitti Journal: Birth Defects Res Date: 2022-06-27 Impact factor: 2.661